Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Psoriasis × Eicosapentaenoic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Psoriasis 1 Polyps 1 Osteoarthritis 1 Leukemia, Myeloid, Chronic-Phase 1 Hyperplasia 1 Colorectal Neoplasms 1 Cancer Cachexia 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1 Adenomatous Polyposis Coli 1

Interventions

tofacitinib 7 Etanercept 4 Methotrexate 2 Adalimumab 2 secukinumab 1 baricitinib 1 apremilast 1 Vitamin D 1 Vaccines 1 Saline Solution 1 Herpes Zoster Vaccine 1 Folic Acid 1 Fish Oils 1 Fatty Acids, Omega-3 1 Eicosapentaenoic Acid 1 Docosahexaenoic Acids 1 Cholecalciferol 1 Anti-Infective Agents, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01351805 2025-12-03

VITAL

Brigham and Women's Hospital

Phase NA Completed

25,871 enrolled 15 charts

Arthritis, Rheumatoid, Autoimmune Diseases, Osteoarthritis, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡